Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury (Q34558395)

3 August 2017

Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury (English)

1 reference

3 August 2017

pulmonary hypertension

1 reference

1 reference

Faruqa Ladha

1

1 reference

3 August 2017

Sebastien Bonnet

2

1 reference

3 August 2017

Farah Eaton

3

1 reference

3 August 2017

Kyoko Hashimoto

4

1 reference

3 August 2017

Greg Korbutt

5

1 reference

3 August 2017

Bernard Thébaud

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

9 June 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

3 August 2017

1 reference

3 August 2017

172

1 reference

3 August 2017

750-756

1 reference

3 August 2017

6

1 reference

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

3 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Prospects for research in reproductive health and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Bronchopulmonary dysplasia: "a vascular hypothesis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic lung injury in preterm lambs. Disordered respiratory tract development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Nitric oxide modulates branching morphogenesis in fetal rat lung explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Sildenafil reverses O2 constriction of the rabbit ductus arteriosus by inhibiting type 5 phosphodiesterase and activating BK(Ca) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-510OC

10.1164/RCCM.200503-510OC

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference